13 Aug 2024 | 03:00 PM GMT

Trends in Mental Health M&A: A Discussion with Movers and Shakers

Participants:

Aaron Gani Founder & CEORealizedCare
Aaron Gani
Founder & CEORealizedCare
Benjamin Alouf Chief Medical OfficerFloreo
Benjamin Alouf
Chief Medical OfficerFloreo
Omar Manejwala Chief Medical OfficerDarioHealth
Omar Manejwala
Chief Medical OfficerDarioHealth
Alice Murphy Community ManagerHLTH
Alice Murphy
Community ManagerHLTH
Aaron Gani Founder & CEOBehaVR, Inc.
Aaron Gani
Founder & CEOBehaVR, Inc.
Anastasia Maroudia Business Development ManagerFeel Therapeutics
Anastasia Maroudia
Business Development ManagerFeel Therapeutics
Ashok Vardhan Head, Oncology Medical Affairs AI InnovationPfizer
Ashok Vardhan
Head, Oncology Medical Affairs AI InnovationPfizer
Chris Cera CEOArcweb Technologies
Chris Cera
CEOArcweb Technologies
Hannes Klöpper FounderHelloBetter
Hannes Klöpper
FounderHelloBetter
Jennifer Kim DirectorIsrael Economic Mission to the USA
Jennifer Kim
DirectorIsrael Economic Mission to the USA
John Stamatopoulos Chief Revenue OfficerKoa Health
John Stamatopoulos
Chief Revenue OfficerKoa Health
Jon Baker CEOiona mind
Jon Baker
CEOiona mind
Liz Mosher Senior Associate, Digital HealthcareStanford Health Care
Liz Mosher
Senior Associate, Digital HealthcareStanford Health Care
Martyna Skowron Lead Strategy & OperationsWorld Economic Forum
Martyna Skowron
Lead Strategy & OperationsWorld Economic Forum
Matt Norton VP of Marketing & Commercial DevelopmentS3 Connected Health
Matt Norton
VP of Marketing & Commercial DevelopmentS3 Connected Health
Michele Davey RN/FounderMurphy Cares
Michele Davey
RN/FounderMurphy Cares
Myles Furnace Chief Commercial OfficerEolas Medical
Myles Furnace
Chief Commercial OfficerEolas Medical
Ralph Morales III Managing DirectorShokunin Ventures
Ralph Morales III
Managing DirectorShokunin Ventures
Robert Jordshaugen Founder and CEOBreakthrough6
Robert Jordshaugen
Founder and CEOBreakthrough6
Steve Seuntjens PartnerPHS Capital
Steve Seuntjens
PartnerPHS Capital
Yelena Chorny Physician, Consultant(Independent Contractor)
Yelena Chorny
Physician, Consultant(Independent Contractor)

About this Meeting

There is a growing spotlight on mental health in our society, and changing societal attitudes towards mental health care is driving attention towards digital health companies offering solutions in this space. As the digital health industry continues to revolutionise the landscape of mental healthcare, investors and buyers are increasingly recognising the potential of digital health companies in this space. Join industry leaders, innovators, and visionaries in a compelling discussion on the recent trends in mental health mergers and and acquisitions. This meeting delves into the strategic alliances, partnerships, and acquisitions reshaping the delivery of mental health services in the digital age.

From startups disrupting traditional models to established players seeking to expand their digital footprint, the conversation explores the driving forces behind recent M&A activities. Participants will gain valuable insights into the motivations, challenges, and opportunities driving consolidation and collaboration within the digital health ecosystem for mental health.

Expect engaging dialogue on topics ranging from emerging technologies like teletherapy and AI-driven diagnostics to regulatory considerations and market dynamics influencing investment decisions. Whether you're an investor, entrepreneur, or healthcare professional, this discussion promises to shed light on the path forward in the ever-evolving landscape of mental health within the digital health industry.


We’ll discuss topics such as:

  • What technology types are garnering attention from buyers and investors in the mental health space?

  • Who are the major players making big bets on digital mental health and what are the driving forces behind M&A decisions in this space?

  • How will the increasing importance of AI-powered solutions change the landscape for M&As in the digital mental health space? Will we see more traction from technology giants and big pharma seeking to augment their portfolios with AI capabilities?